# FDA Inspection 1102650 - Rentschler Biopharma SE - August 09, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/rentschler-biopharma-se/41551671-1c8f-41a7-8269-faa6cb1760fb/
Source feed: FDA_Inspections

> FDA Inspection 1102650 for Rentschler Biopharma SE on August 09, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102650
- Company Name: Rentschler Biopharma SE
- Inspection Date: 2019-08-09
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1246782 - 2023-05-05](https://www.globalkeysolutions.net/api/records/fda_inspections/rentschler-biopharma-se/0d912736-9230-4aef-96a6-874067c47f8c/)
- [FDA Inspection 1160831 - 2021-02-26](https://www.globalkeysolutions.net/api/records/fda_inspections/rentschler-biopharma-se/5c3bee2b-f543-44ea-878b-b0b820cae70f/)
- [FDA Inspection 999800 - 2016-12-06](https://www.globalkeysolutions.net/api/records/fda_inspections/rentschler-biopharma-se/fd3c2655-b57f-4166-9399-c3a17930da99/)
- [FDA Inspection 933400 - 2015-06-16](https://www.globalkeysolutions.net/api/records/fda_inspections/rentschler-biopharma-se/72b19de5-5f32-4b03-9fbb-09b85a00b404/)
- [FDA Inspection 853179 - 2013-09-20](https://www.globalkeysolutions.net/api/records/fda_inspections/rentschler-biopharma-se/6d4b4198-45a4-431a-ba15-bbc0d85ac1b2/)

Company: https://www.globalkeysolutions.net/companies/rentschler-biopharma-se/da50fa41-24f6-449f-bf90-45eccb97d9ba

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c